Proposed Acthar Giveaway May Violate Anti-Kickback Statue, OIG Says

Drug Industry Daily
Mallinckrodt’s proposed patient access program for its Acthar gel injection could open the door for fraud and abuse under the Anti-Kickback statute, the HHS Office of the Inspector General (OIG) warned in response to the drugmaker’s inquiries.

To View This Article:


Subscribe To Drug Industry Daily